Clinical trial
Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients…
NCT00363129 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00363129 |
|---|---|
| Title | Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer |
| Official title | The Use of Vitamin E for Prevention of Chemotherapy Induced Peripheral Neuropathy: A Phase III Double-Blind Placebo Controlled Study |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Other |
| Interventions | vitamin E, placebo |
| Enrollment | 207 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Aug 1, 2014 |
| First posted | Aug 15, 2006 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: